China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Predictive Factors for the Impact of Matrix-Type Fentanyl Patches on Immunotherapy Efficacy in Cancer Pain Patients.'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132776
Registration Time: 2026/09/18
Type: Observational study
Primary Sponsor: Xuzhou Central Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=280122
Published by HT Digital Content Services with permission from Health Daily Digest....